Do we need to see to believe?—radiomics for lung nodule classification and lung cancer risk stratification

Despite multiple recent advances, the diagnosis and management of lung cancer remain challenging and it continues to be the deadliest malignancy. In 2011, the National Lung Screening Trial (NLST) reported 20% reduction in lung cancer related mortality using annual low dose chest computed tomography...

Descripción completa

Detalles Bibliográficos
Autores principales: Khawaja, Ali, Bartholmai, Brian J., Rajagopalan, Srinivasan, Karwoski, Ronald A., Varghese, Cyril, Maldonado, Fabien, Peikert, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Novel Diagnostic Techniques for Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330769/
https://www.ncbi.nlm.nih.gov/pubmed/32642254
http://dx.doi.org/10.21037/jtd.2020.03.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330769/
https://www.ncbi.nlm.nih.gov/pubmed/32642254
http://dx.doi.org/10.21037/jtd.2020.03.105

Ejemplares similares